These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8621896)

  • 41. Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication.
    Secchiero P; Zella D; Curreli S; Mirandola P; Capitani S; Gallo RC; Zauli G
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14620-5. PubMed ID: 11114167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.
    Mitola S; Soldi R; Zanon I; Barra L; Gutierrez MI; Berkhout B; Giacca M; Bussolino F
    J Virol; 2000 Jan; 74(1):344-53. PubMed ID: 10590123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular immunopathogenesis of HIV infection.
    Ng TT; Pinching AJ; Guntermann C; Morrow WJ
    Genitourin Med; 1996 Dec; 72(6):408-18. PubMed ID: 9038636
    [No Abstract]   [Full Text] [Related]  

  • 44. Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.
    Fergelot P; Molina T; Blanchet P; Grimber G; Duquenne O; Couton D; Zider A; Briand P; Cavard C
    C R Acad Sci III; 1995 Mar; 318(3):329-37. PubMed ID: 7788501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice.
    Prakash O; Zhang P; Xie M; Ali M; Zhou P; Coleman R; Stoltz DA; Bagby GJ; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2043-9. PubMed ID: 9884149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice.
    Garza HH; Prakash O; Carr DJ
    J Immunol; 1996 May; 156(10):3631-7. PubMed ID: 8621896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM; Jeang KT
    Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.